— Know what they know.
Not Investment Advice
Also trades as: CHGX.CN (CNQ) · $vol 0M

CHNXF OTC

ChitogenX Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +48.0% 3Y: -95.4% 5Y: -98.2%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 39 · $627628 mcap · 59M float · 0.070% daily turnover · Short 74% of daily vol

Balance Sheet Trends

Total Assets
$534K -27.6% ▼
5Y CAGR: -19.8%
Total Liabilities
$7M -36.6% ▼
5Y CAGR: +25.1%
Shareholders Equity
-$6M +37.2% ▲
Cash & Investments
$35K -67.6% ▼
5Y CAGR: -41.8%
Total Debt
$4M -30.4% ▼
5Y CAGR: +27.4%
Net Debt
$4M -29.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$302K$2M$313K$108K$35K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$302K$2M$313K$108K$35K
Net Receivables$375K$203K$289K$167K$89K
Inventory$0$0$0$0$0
Other Current Assets$271-$160$118-$655$7
Total Current Assets$741K$3M$722K$396K$234K
Property, Plant & Equip.$150K$73K$69K$43K$33K
Goodwill & Intangibles$396K$364K$332K$299K$267K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$546K$437K$401K$342K$300K
Total Assets$1M$3M$1M$738K$534K
— Liabilities —
Accounts Payable$998K$241K$466K$1M$2M
Short-Term Debt$596K$2M$934K$3M$596K
Deferred Revenue$0$0$12K$0$0
Other Current Liabilities$0$0$139K$2M$0
Total Current Liabilities$2M$2M$2M$7M$3M
Long-Term Debt$2M$3M$5M$2M$3M
Other Non-Current Liab.$0$0$2M$996K$164K
Total Non-Current Liabilities$2M$3M$6M$3M$3M
Total Liabilities$4M$5M$8M$11M$7M
— Equity —
Common Stock$5M$8M$8M$10M$14M
Retained Earnings-$10M-$14M-$19M-$25M-$27M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$2M-$2M-$7M-$10M-$6M
Total Liabilities & Equity$1M$3M$1M$738K$534K
— Key Metrics —
Total Debt$3M$5M$6M$6M$4M
Net Debt$2M$2M$5M$5M$4M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms